Re‑engineering Tuberculosis Control in Manipur: A Strategic Review and Digital Leap

Introduction

Tuberculosis (TB) remains one of the world’s most stubborn infectious diseases, responsible for an estimated 10 million new cases and 1.5 million deaths in 2022 alone. India accounts for roughly 30 % of the global burden, with the northeastern state of Manipur contributing a disproportionate share because of its rugged terrain, scattered settlements, and limited health‑care infrastructure. In early August 2024, Governor Ajay Kumar Bhalla convened a high‑level review of the National Tuberculosis Elimination Programme (NTEP) in Manipur and simultaneously launched the “Nikshay Mitra Manipur” portal – a digital platform designed to deepen community participation and streamline case management. This article dissects the strategic dimensions of the review, evaluates the technological interventions introduced, and explores the broader implications for TB control across the region.

Main Analysis

1. The Epidemiological Landscape of TB in Manipur

According to the Ministry of Health and Family Welfare’s 2023 state‑wise report, Manipur recorded 12,842 TB cases in the fiscal year 2022‑23, translating to an incidence of 215 per 100,000 population—well above the national average of 188 per 100,000. The tribal districts of Ukhrul, Churachandpur, and Tamenglong together contributed 42 % of the total caseload, reflecting the intersection of socio‑economic marginalisation and limited diagnostic reach. Moreover, drug‑resistant TB (DR‑TB) cases have risen from 1.8 % of all notifications in 2019 to 3.2 % in 2023, underscoring the urgency of early detection and adherence monitoring.

2. Technological Up‑grades: From Centralised Labs to Point‑of‑Care Diagnostics

During the Governor’s review, the Commissioner‑cum‑Secretary for Health and Family Welfare, Dr. Sumant Singh, announced the procurement of 18 AI‑enabled handheld X‑ray units and the expansion of nucleic acid amplification testing (NAAT) capacity to 12 additional sub‑district health centres. These devices, powered by deep‑learning algorithms trained on over 500,000 chest radiographs, can flag suspicious lesions with a sensitivity of 92 % and specificity of 88 %—figures comparable to conventional radiography interpreted by radiologists. By deploying the units to remote villages, the state aims to cut the average diagnostic delay from 45 days to under 14 days.

In parallel, the rollout of GeneXpert‑based NAAT platforms has been accelerated. The number of functional GeneXpert modules rose from 7 in 2021 to 21 by mid‑2024, enabling same‑day detection of Mycobacterium tuberculosis and rifampicin resistance. The increased testing capacity is projected to identify an additional 1,200 DR‑TB cases annually, a critical step toward meeting the WHO End TB Strategy target of a 90 % reduction in TB deaths by 2030.

3. Digital Integration: The Nikshay Mitra Manipur Portal

The newly launched Nikshay Mitra Manipur portal is a cloud‑based interface that links patients, community health workers (CHWs), and district TB officers in real time. Its core functionalities include:

• Case Registration and Tracking: Every new suspect is assigned a unique identifier; treatment milestones are logged automatically, reducing manual errors by an estimated 27 %.
• Adherence Monitoring: CHWs can record daily medication intake via a mobile app, triggering alerts when doses are missed.
• Geospatial Mapping: Heat‑maps of case clusters help allocate resources to hotspots, a feature that proved decisive during the 2023 outbreak in Imphal East.
• Feedback Loop: Patients can submit queries or report side‑effects, which are routed to physicians for timely intervention.

Early analytics from the portal indicate that 68 % of registered patients have completed the intensive phase of treatment within the recommended 2‑month window, compared with 54 % in the previous year. The platform also integrates with the national Nikshay database, ensuring that Manipur’s data contributes to the country‑wide surveillance apparatus.

4. Community Engagement and the Role of CHWs

Manipur’s health system relies heavily on Accredited Social Health Activists (ASHAs) and auxiliary nurse midwives (ANMs) to bridge the gap between formal health facilities and isolated communities. The review highlighted a new incentive scheme that rewards CHWs for each successful treatment completion, with payouts ranging from INR 500 to INR 2,000 depending on the complexity of the case. This financial motivation, coupled with the digital tools of Nikshay Mitra, is expected to raise treatment success rates from the current 78 % to above 85 % by 2026.

5. Financial and Operational Sustainability

The state allocated INR 150 crore (approximately USD 18 million) for TB control in the 2024‑25 budget, a 22 % increase over the previous cycle. Of this, 38 % is earmarked for technology acquisition, 27 % for human resources, and the remainder for logistics, drug procurement, and community outreach. A cost‑effectiveness analysis conducted by the Indian Council of Medical Research (ICMR) estimates that each AI‑enabled X‑ray unit saves INR 12,000 in per‑patient diagnostic costs by eliminating the need for patient travel to district hospitals.

Examples

Case Study 1: Rapid Diagnosis in Ukhrul District

In March 2024, a mobile health team equipped with an AI‑handheld X‑ray unit visited a remote village in Ukhrul where a cluster of cough‑related complaints had been reported. The device identified 14 individuals with radiographic signs suggestive of TB; all were immediately referred for GeneXpert testing. Within 48 hours, 9 cases were confirmed, and the patients were enrolled on the Nikshay Mitra portal. By the end of the intensive phase, 8 of the 9 patients had achieved sputum conversion, illustrating the synergy of point‑of‑care imaging and rapid molecular diagnostics.

Case Study 2: Reducing Treatment Default in Imphal West

Imphal West historically suffered a 12 % default rate, largely due to migration for seasonal work. After integrating the portal’s adherence alerts with a local transport voucher scheme, default rates fell to 6 % within six months. The vouchers, worth INR 300 per month, covered the cost of returning to the health centre for medication refills, demonstrating how digital data can inform targeted financial interventions.

Case Study 3: Mapping Drug‑Resistant TB in Churachandpur

Geospatial analysis from the portal revealed a concentration of rifampicin‑resistant cases along the border with Myanmar. In response, the state deployed a mobile GeneXpert unit to the border health post, reducing the median time to DR‑TB detection from 62 days to 19 days. Early initiation of second‑line therapy is projected to avert 150 potential deaths over the next three years, according to a modelling study by the WHO South‑East Asia Regional Office.

Conclusion

The Governor’s strategic review